Skip to search.
 FTSE 100 Down 1.27%

Inovio Pharmaceuticals, Inc. (INO)

-NasdaqGS
10.48 Down 0.70(6.26%) 29 Apr 21:00
|After Hours: : 10.53 Up 0.05 (0.48%) 00:14
Prev Close:11.18
Open:11.28
Bid:10.52 x 500
Ask:11.70 x 700
1y Target Est:18.60
Beta:2.90938
Earnings Date:9 May - 13 May (Est.)
Day's Range:10.20 - 11.50
52wk Range:4.50 - 11.69
Volume:3,065,002
Avg Vol (3m):2,072,070
Market Cap:756.91m
P/E (ttm):N/A
EPS (ttm):-0.30
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

  • No Headlines available for INO at this time.

Comparison

Symbol% ChgMkt Cap
INODown 6.26%756.91m
PFEDown 0.61%202.54b
AZNDown 1.06%73.21b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.76
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-0.53
Quarterly EPS Est (Mar-16) :-0.14
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Inovio Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops active DNA immunotherapies and vaccines in combination with proprietary electroporation delivery devices to prevent and treat cancers and infectious diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback